FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...